Renin inhibitors for the treatment of hypertension

Details for Australian Patent Application No. 2007234917 (hide)

Owner Novartis AG

Inventors Satlin, Andrew

Agent Davies Collison Cave

Pub. Number AU-B-2007234917

PCT Pub. Number WO2007/118023

Priority 60/788,842 03.04.06 US

Filing date 30 March 2007

Wipo publication date 18 October 2007

Acceptance publication date 12 May 2011

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/118023 Priority application(s): WO2007/118023

12 May 2011 Application Accepted

  Published as AU-B-2007234917

8 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007234940-Diagnostic meter

2007234906-Identification of an anomalous orientation definition condition of a remote locomotive of a train